Evidence map›Paper›PMID 38474579›Full record

ArticleMolecules (Basel, Switzerland)2024

Designing Potent Anti-Cancer Agents: Synthesis and Molecular Docking Studies of Thieno[2,3-

Eman S M Elsenbawy, Zafer S Alshehri, Nouf A Babteen, Adel A-H Abdel-Rahman, Mai A El-Manawaty, Eman S Nossier, Reem K Arafa, Nasser A Hassan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Discovery of thieno[3,2-RSC advances · 2026
    Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eman S M ElsenbawyDepartment of Chemistry, Faculty of Science, Menofia University, Shbien El-Kom 32511, Egypt.
Zafer S AlshehriDepartment of Medical Laboratories, College of Applied Medical Sciences, Shaqra University, Dawadmi 19257, Saudi Arabia.
Nouf A BabteenDepartment of Biochemistry, College of Sciences, University of Jeddah, Jeddah 21577, Saudi Arabia.
Adel A-H Abdel-RahmanDepartment of Chemistry, Faculty of Science, Menofia University, Shbien El-Kom 32511, Egypt.
Mai A El-ManawatyDepartment of Pharmacognosy, Pharmaceutical Science Division, National Research Centre, Cairo 12622, Egypt.
Eman S NossierDepartment of Pharmaceutical Medicinal Chemistry and Drug Design, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo 11754, Egypt.ORCID 0000-0001-6159-5333
Reem K ArafaDrug Design and Discovery Laboratory, Biomedical Sciences Program, University of Science and Technology, Zewail City of Science and Technology, Ahmed Zewail Road, October Gardens, Cairo 12578, Egypt.ORCID 0000-0001-7527-1655
Nasser A HassanSynthetic Unit, Department of Photochemistry, Chemical Industries Research Institute, National Research Centre, Cairo 12622, Egypt.ORCID 0000-0003-1809-9232

Funding

Shaqra University SU-ANN-202215
6 · The paper itself

Abstract

A new series of thieno[2,3-

Indexed as

Antineoplastic AgentsCell Line, TumorCell ProliferationDrug DesignDrug Screening Assays, AntitumorHumansMolecular Docking SimulationMolecular StructurePyrimidinesStructure-Activity RelationshipTriazolesAntineoplastic AgentsPyrimidinesTriazolesADMEanti-cancer agentsmolecular dockingsynthesisthieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidinesthieno[3,2-d]pyrimidin-4(3H)-one derivatives

Identifiers

PMID38474579
PMCPMC10934261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.